Central Venous Disease in Hemodialysis Patients

Abstract

Background: The literature surrounding central venous disease (CVD) in hemodialysis patients has expanded significantly over the past decade, revealing critical insights into its prevalence, pathophysiology, and management strategies. Literature Review: The foundational work by Krycińska et al. (2015) identified the anatomical vulnerabilities associated with CVD, particularly emphasizing the high incidence of stenosis at the subclavian-brachiocephalic vein junction (Krycińska et al., 2015). This early research set the stage for subsequent studies that further explored the implications of central venous catheter (CVC) usage, particularly the risks associated with subclavian access, which has been shown to significantly increase the likelihood of developing venous stenosis. The exploration of stenting as a therapeutic intervention was further advanced by Eguchi and Honma (Eguchi & Honma, 2020), who discussed the management of venous hypertension and the off-label use of bare metal stents (BMS). They underscored the potential risks associated with stenting, including vascular injury and stent migration, which were echoed by Ma et al. (2018), who linked the development of central venous stenosis and occlusion to prior catheter placements. eyra and Wazir (Roxana Neyra & Wazir, 2022) provided a broader perspective on vascular access management, particularly in light of the COVID-19 pandemic, highlighting the importance of infection control measures and their positive impact on patient outcomes. Their findings reinforce the need for continuous innovation and adaptation in treatment protocols to enhance care for hemodialysis patients. Conclusion: In conclusion, the cumulative knowledge from these studies illustrates the complexity of central venous disease in hemodialysis patients. It highlights the interplay between treatment modalities, anatomical considerations, and patient management strategies. The ongoing research in this area reveals an urgent need for further studies to refine therapeutic approaches and improve long-term outcomes for this vulnerable population.